The Global Blood Gas Analyzers Market, by Product Type (Bench Top and Portable), by Application (Anesthesia, Cardiovascular Surgery, ICU, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
was valued at US$ 594.6 million
in 2017 and is projected to exhibit a CAGR of 5.5%
over the forecast period (2018 - 2026), as highlighted in a new report published by .
In emergency and critical care settings blood tests, which specifically include provision of blood gases can improve clinical decision-making and patient outcomes. Several hospitals have implemented bedside testing for blood gases either on an institutional level or more commonly, in selected patient care settings such as pulmonary unit, emergency department, and neonatal intensive care. This reduces operational cost and improves staff efficiency, which may further enhance clinical outcomes.
Technological advancements in blood gas analyzers such as easy to operate and ready to use features are boosting their adoption in medical settings. Increasing demand for Point-of-Care (PoC) testing leads to fast and accurate blood gas analysis. Key market players are focused on developing portable blood gas analyzers in order to increase usability and comfort.
For instance, in April 2018, Radiometer Limited launched its CE-marked point-of-care tests for creatinine and urea, which is the latest additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu. The versatile ABL90 FLEX PLUS is considered to be the only compact blood gas analyzer in the market to offer such an extensive range of critical care parameters including blood gas, electrolytes, metabolites, and co-oximetry.
Moreover, in 2015, Sphere Medical, launched arterial blood gas analyzer, Proxima System in Europe. The device delivers efficient PoC testing as it offers frequent blood gas measurements at the patient’s bedside. This facilitates effective and timely clinical decisions for proactive critical care.
Browse 32 Market Data Tables and 21 Figures spread through 153 Pages and in-depth TOC on "Blood Gas Analyzers Market, by Product Type (Bench Top and Portable), by Application (Anesthesia, Cardiovascular Surgery, ICU, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to blood gas analyzers market, click the link below:
Key Takeaways of the Blood gas analyzers Market:
- The global blood gas analyzers market is expected to expand at a CAGR of 5.5% during the forecast period, owing to increasing demand for PoC testing.
- Among product type, the portable blood gas analyzer segment is expected to witness highest growth rate in 2026, due to ease of use provided by these devices in comparison to bench top products
- Major players operating in the global blood gas analyzers market include, Abbott Laboratories, Alere, Inc., Bayer AG, Dalko Diagnostics, GE Healthcare, Instrumentation Laboratory, Nova Biomedical, Radiometer, Roche Diagnostics, Siemens Healthcare, and Sphere Medical